Remove 2019 Remove Public Trading Remove Valuation
article thumbnail

Cooley’s 2019 Life Sciences M&A Year in Review

Cooley M&A

2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2

M&A 40
article thumbnail

Fiscal Quarter

Wall Street Mojo

The same is vital for the publicly traded companies as they must present specific information on an ongoing basis to the Securities and Exchange Commission concerning their quarterly performance in form 10-Q. You are free to use this image o your website, templates, etc, Please provide us with an attribution link How to Provide Attribution?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hopin, the struggling virtual conference unicorn, sells events and engagement units to RingCentral

TechCrunch: M&A

Hopin , the virtual events startup that saw its star (and valuation) rise quickly during the COVID-19 pandemic, is most definitely coming down to earth. Today the company announced that it has sold its Events and Session business units to RingCentral for an undisclosed sum. It will be using the new assets to further diversify its business.

Business 202
article thumbnail

Will There Be an IPO for a Specialty Consulting Company in 2024?

Focus Investment Banking

There are only a few publicly traded companies in specialty consulting. But those companies have been public for more than 20 years. He advises business owners on sell-side and buy-side transactions, valuation analysis, corporate finance and equity and debt financing. Contact Kelly at Kelly.Kittrell@focusbankers.com.

IPO 52
article thumbnail

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

Given that a SPAC is an alternative means to going public, a significant portion of the webinar was dedicated to discussing some of the key differences—and similarities—between a SPAC and a traditional IPO. Valuation Certainty. Competition / Variation. Another feature of SPAC 3.0 is the competition among SPACs for potential targets.

M&A 52
article thumbnail

Cooley’s 2020 Tech M&A Year in Review

Cooley M&A

Although global deal value was a subdued $966 billion in the first half of 2020 (down nearly 50% compared to the first half of 2019), momentum skyrocketed in the second half of the year to nearly $2.2 compared to 2019. compared to 2019, and up even higher (57%) when looking solely at US deal value. COVID-19: The New Normal.

M&A 40
article thumbnail

Keeping Up with Delaware Appraisal Jurisprudence Since Aruba: Deal Price Reigns Supreme, But Will Recent Decision Lead to More Arbitrage?

Cooley M&A

In a string of seminal decisions from 2017 through 2019 ( DFC Global , Dell and Aruba ), the Delaware Supreme Court re-shaped appraisal jurisprudence, in each case by overturning the Court of Chancery for failing to give adequate weight to deal price as the most reliable indicator of fair value. took private in 2017 for $315/share.